Episode 37: Differentiating Yourself in Crowded Therapeutic Areas
Aug 8, 2019
20:39
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Pharm Exec editors sit down with Mark Velleca, CEO of G1 Therapeutics. In this episode, Mark talks about how he differentiates himself in the oncology field, why he considers G1 Therapeutics an "old school company," and about the North Carolina biotech landscape.
Pharmaceutical Executive